Web Results

Cipher Pharmaceuticals


Cipher Pharmaceuticals is a growing specialty company with a focus on dermatology. Our goal is to develop and acquire best-in-class skin care solutions.

Innocutis Medical, LLC: Private Company Information - Businessweek


Innocutis Medical, LLC company research & investing information. ... United States by its commercial partner, Innocutis Holdings, and the granting of a new U.S. ...

Charleston drug company sold for $45.5M to Canada's Cipher ...


Apr 16, 2015 ... Among other dermatological remedies, Innocutis markets the ... said it acquired privately held Innocutis Holdings LLC for $45.5 million in cash ...

Innocutis Holdings LLC - Company Profile - BioCentury


Apr 2, 2012 ... Innocutis' detailed financings; Comprehensive pipeline breakdown, including molecular targets & partnerships. 17 years of in-depth BioPharma ...

Charles F. Jenkins | LinkedIn


Cipher Pharmaceuticals Inc. Previous. Innocutis Holdings, LLC,; Innocutis Medical, LLC,; Medicis. Education. University of South Carolina-Columbia. Websites.

DailyMed - UMECTA UREA- urea film


NDC Code(s): 68712-010-01, 68712-010-03, 68712-010-04; Packager: Innocutis Holdings LLC. Category: HUMAN PRESCRIPTION DRUG LABEL; DEA ...

DailyMed - UMECTA PD UREA- urea emulsion


More Info For This Drug. View Label Archives; RxNorm; Get Label RSS Feed. NDC Code(s): 68712-017-01, 68712-017-02; Packager: Innocutis Holdings LLC.

DailyMed - UMECTA MOUSSE UREA - urea aerosol, foam


NDC Code(s): 68712-020-01; Packager: Innocutis Holdings LLC. Category: HUMAN PRESCRIPTION DRUG LABEL; DEA Schedule: None; Marketing Status:  ...

Cipher Pharmaceuticals enters US market with Innocutis acquisition


Apr 13, 2015 ... Cipher Pharmaceuticals, a Canada-based specialty pharmaceutical dermatology company, has acquired Innocutis Holdings, a Charleston, ...

Cipher Pharma maps out its path to success - The Globe and Mail


Apr 21, 2015 ... ... company Innocutis Holdings LLC for $45.5-million (U.S.) in cash, its ... Innocutis gives Cipher critical infrastructure to sell its products in the ...

More Info

Cipher Pharmaceuticals announces U.S. commercial entry through ...


Apr 13, 2015 ... ... that it has acquired INNOCUTIS Holdings LLC ("INNOCUTIS"), a privately held specialty dermatology company, for US$45.5 million in cash.

Cipher Pharmaceuticals acquires INNOCUTIS Holdings ... - Onxeo


Apr 13, 2015 ... oncology drugs, today announced Cipher Pharmaceuticals' (NASDAQ: CPHR) acquisition of INNOCUTIS. Holdings LLC, the licensee of ...

innocutis | CrunchBase


Innocutis is a pharmaceutical and medical device company developing ... Founded: 2005; Aliases: Innocutis Holdings, LLC; Employees: 1 in CrunchBase.